Nolan Garry Ph.D. 4
4 · Akoya Biosciences, Inc. · Filed Nov 17, 2022
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Sale
Common Stock
2022-11-16$13.25/sh−300$3,976→ 598,078 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $13.25 and $13.26, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.